Bookmark

Add to MyYahoo RSS

Merck & Co. News

News on Merck & Co. (Ticker: MRK) continually updated from thousands of sources around the net.

Monday Aug 18 | AmericanBankingNews.com

Merck & Co. Stock Rating Reaffirmed by Zacks

's stock had its "neutral" rating reissued by Zacks in a note issued to investors on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck

Sat Aug 16, 2014

WTVC

Hazardous Material Crews Responded to Merck and Company

U.S. factory output rose for the sixth consecutive month in July, led by a jump in the production of motor vehicles, furniture, textiles and metals.

Comment?

Related Topix: West Palm Beach, FL, Palm Beach, FL

Tue Aug 12, 2014

Seeking Alpha

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies

Tumor cells that refuse to die have led researchers to develop immuno-oncology drugs, a brand new class, with Big Pharma participation.

Comment?

Related Topix: Oncology, Medicine, Biotech, Bristol Myers Squibb, Healthcare Industry, Medarex, Dendreon, Merck

MarketNewsVideo

Dow Movers: CVX, MRK

In early trading on Tuesday, shares of Merck & Co. topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.5%.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Chevron Corporation, Energy, Oil & Gas, Business News, Video

Mon Aug 11, 2014

Seeking Alpha

Enanta Pharmaceuticals Is Simply Too Cheap To Ignore

Based on my conservative revenue estimates, I believe Enanta will easily double from current levels within the next 12 months.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Johnson and Johnson, Merck , Idenix Pharmaceuticals, Healthcare Law, Law

AmericanBankingNews.com

Merck & Co. Price Target Cut to $60.00

Jefferies Group's target price indicates a potential upside of 6.10% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Startups, Bain & Company, Vaccine Company

Fri Aug 08, 2014

BayStreet.ca

Small companies lead the I-O class of Cancer Therapies

Los Angeles, CA / August 8, 2014 / Tumor cells, tending to persist after treatment, lead to remission and have been a bane to cancer researchers and doctors for decades.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Oncology, Medarex, Dendreon, Merck

Wed Aug 06, 2014

Seeking Alpha

Gilead Is Going To Make More Money In The Future

Gilead Sciences is one of the more compelling companies on the market. Anyone who is familiar with the company is aware that Sovaldi is hailed as a cure for hepatitis C, and prevents the need for 'costly' alternatives such as a liver transplant.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health, Merck , Startups, Bain & Company, Vaccine Company

Sat Aug 02, 2014

AmericanBankingNews.com

Merck & Co. PT Raised to $62.00 at BMO Capital Markets

BMO Capital Markets' price objective would suggest a potential upside of 9.15% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck

Fri Aug 01, 2014

Philly.com

Job growth in July signals more progress

U.S. payrolls grew by 209,000 jobs in July - less than expected, but still enough to begin to erase the jobs deficit created by the recession, the U.S. Labor Department reported Friday.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry

Thu Jul 31, 2014

AmericanBankingNews.com

Merck & Co. Given "Neutral" Rating at Credit Suisse

's stock had its "neutral" rating reaffirmed by research analysts at Credit Suisse in a report released on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck

Tue Jul 29, 2014

Benzinga

Tuesday Morning Earnings Releases

Arrow Electronics reported its Q2 2014 earnings. The company reported an EPS of $1.43, above estimates of $1.42, and revenue for the quarter of $2.68 billion compared to estimates of $5.69 billion.

Comment?

Related Topix: Electronics, Arrow Electronics, Anixter Intl, Biotech, Merck , Medicine, Healthcare Industry, Publishing, Media, New Times

Salt Lake Tribune

Merck's second-quarter profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Zetia, Ezetimibe (generic), Whitehouse Station, NJ, AstraZeneca, AstraZeneca Group

The Beaumont Enterprise

Merck 2Q profit more than doubles

In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Whitehouse Station, NJ

Fri Jul 25, 2014

Philly.com

Merck to cut 600 jobs in Montco

Merck & Co., which is reorganizing to slash $2.5 billion in costs and 8,500 workers, has informed Pennsylvania officials that it will cut 600 jobs at facilities in North Wales and Lansdale.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Pennsylvania, Law, Employment / Labor Law

Thu Jul 24, 2014

Seeking Alpha

Merck Looks Overpriced Compared To This Sector Peer

We pitch two companies from the pharmaceutical sector, Merck and AbbVie, against one another in the latest installment of our Head-To-Head series.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Startups, Bain & Company, Vaccine Company, Women's Health

Wed Jul 23, 2014

jdsupra.com

IPR Update -- The First Pharma IPR Decisions

Late last month, while many of us were getting ready to attend the BIO International Convention in San Diego, the Patent Trial and Appeal Board issued four related inter partes review opinions, marking what many have called the first set of opinions related to the Pharmaceutical industry.

Comment?

Related Topix: Healthcare Law, Law, Bain & Company, Folic Acid, Supplement

Business Journal

Biopharma industry at highest risk for employee turnover

A new survey reveals it might be easier for companies in the biopharma industry to poach employees from one another, especially among employees who view themselves as underpaid.

Comment?

Related Topix: Research Triangle Park, NC, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Merck

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••